2013年国际抗癫痫青年组织抗癫痫药使用指南
2022-04-25 11:54:31 来源: 河源 咨询医生
he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看信源地址
下一页:一文掌握癫痫用药一部
- 2022-04-26一文掌握癫痫用药一部
- 2022-04-252013年国际抗癫痫青年组织抗癫痫药使用指南
- 2022-04-25癫痫患儿失踪简析
- 2022-04-05综述:癫痫持续状态诊治最新进展
- 2021-11-04复杂性中风癫痫病预防的方法
- 癫痫治疗障碍仍难以克服
- 银屑病药物 Brodalumab 自杀倾向副作用AZ 遭受重创
- 断奶并不可怕,更不用说紧张了,应该这样做
- 预测癫痫患者再入院风险
- 银屑病常用药物进入医疗保险,有效减轻患者的医疗负担
- 综述:癫痫持续状态诊治最新进展
- 癫痫猝死:凶手是谁?
- BMJ:妊娠长短与子宫内膜癌风险
- 月经性癫痫患者妊娠期癫痫控制更好
- 儿童癫痫的早期症状 癫痫的原因
- 癫痫定位新方法:无框架立体定向脑电图技术
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 癫痫会遗传吗 癫痫的治疗方法
- 幕后推手诱发男性更年期
- 症状有哪些?
- 如何最有效地去除黑头?
- 癫痫饮食有哪些禁忌?
- 癫痫患者手术评估新型工具
- 诺华Cosentyx欧盟批准治疗中重度斑块状银屑病
- 2015 神经系统疾病诊疗进展
- 小偏方头部治疗?中医头部治疗?蚯蚓民间偏方?
- 治疗白癜风的阿普斯特临床数据
- 女生有妇科炎症,能自愈吗?
- 癫痫患者如何克服忘记吃药的问题?
- 癫痫的治疗方法 中医拔罐治疗癫痫的小方法(2)
- 注射激素会导致外周色素减少和萎缩
- 手足口病的初始症状 手足口病的表现是什么?
- 睡眠不好怎么办 睡眠不好竟然会灾难性(2)
- 睡觉时接二连三抽搐一下 新生儿睡觉抽搐怎么办
- 类似的癫痫病治疗方法 选择合适的才好
- 老年人得了癫痫病有什么呕吐
- 父母怎样分辨孩子是不是癫痫?出现这些呕吐,家长不可大意!
- 老年癫痫病患者发病的病因主要是有哪些
- 阿尔茨海默病或是人类所特有疾病,同神经元及神经环路活性异常相关
- 猪血的做法 老少皆宜的紫花佳品(14)
- 小儿癫痫的早期症状 癫痫的情况
- 7岁前是治疗癫痫的黄金时期 类似癫痫治疗有哪些
- 癫痫病的诊断要了解什么腹泻
- 地狱科普:小儿癫痫有哪些症状特征?
- 成年人癫痫有哪些疾病